66 related articles for article (PubMed ID: 19713706)
1. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.
Caliskan Y; Yelken B; Ozkok A; Gorgulu N; Yazici H; Telci A; Yildiz A
BMC Nephrol; 2012 Jul; 13():56. PubMed ID: 22768976
[TBL] [Abstract][Full Text] [Related]
2. Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia.
Przybyszewska J; Zekanowska E; Kedziora-Kornatowska K; Boinska J; Cichon R; Porzych K
J Nutr Health Aging; 2011 Apr; 15(4):259-64. PubMed ID: 21437556
[TBL] [Abstract][Full Text] [Related]
3. Iron metabolism in hemodialyzed patients - a story half told?
Malyszko J; Koc-Zorawska E; Levin-Iaina N; Slotki I; Matuszkiewicz-Rowinska J; Glowinska I; Malyszko JS
Arch Med Sci; 2014 Dec; 10(6):1117-22. PubMed ID: 25624847
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients.
Takasawa K; Tomosugi N; Takaeda C; Maeda T; Ueda N
Nephron Extra; 2014 Jan; 4(1):55-63. PubMed ID: 24847351
[TBL] [Abstract][Full Text] [Related]
6. Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.
Brătescu LO; Bârsan L; Gârneaţă L; Stanciu A; Lipan M; Stancu SH; Mircescu G
Int Urol Nephrol; 2014 May; 46(5):1005-12. PubMed ID: 24800994
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Gaillard CA; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
PLoS One; 2012; 7(7):e39783. PubMed ID: 22808058
[TBL] [Abstract][Full Text] [Related]
8. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors.
Pasricha SR; McQuilten Z; Westerman M; Keller A; Nemeth E; Ganz T; Wood E
Haematologica; 2011 Aug; 96(8):1099-105. PubMed ID: 21508121
[TBL] [Abstract][Full Text] [Related]
9. Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy.
Jairam A; Das R; Aggarwal PK; Kohli HS; Gupta KL; Sakhuja V; Jha V
Indian J Nephrol; 2010 Jul; 20(3):125-31. PubMed ID: 21072151
[TBL] [Abstract][Full Text] [Related]
10. Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.
Malyszko J; Malyszko JS; Mysliwiec M
Ren Fail; 2009; 31(7):544-8. PubMed ID: 19839848
[TBL] [Abstract][Full Text] [Related]
11. Assessing iron status: beyond serum ferritin and transferrin saturation.
Wish JB
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
[TBL] [Abstract][Full Text] [Related]
12. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome.
Kato A
Future Cardiol; 2010 Nov; 6(6):769-71. PubMed ID: 21142632
[TBL] [Abstract][Full Text] [Related]
13. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
[TBL] [Abstract][Full Text] [Related]
14. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
15. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
